'De novo' presentation slideshows

Trinucleotide satellite lengths and AR transcriptional activity

Trinucleotide satellite lengths and AR transcriptional activity The androgen receptor gene contains two polymorphic trinucleotide microsatellites in exon 1. The first microsatellite (nearest the 5' end) contains 8 to 60 repetitions of the glutamine codon "CAG"

928 views • 82 slides

Nucleotides metabolism

Nucleotides metabolism. ? ????? ?. ????????????????????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????????????? ???????????????? - ?????????? ???????????????????????????????????????????????????????????????????????????. Outline.

1.01k views • 70 slides

Kyle J. Myers, Ph.D. Director, Division of Imaging, Diagnostics, and Software Reliability

FDA's role in the innovation and evaluation of evolving computer-aided diagnosis (CAD) solutions. Kyle J. Myers, Ph.D. Director, Division of Imaging, Diagnostics, and Software Reliability Office of Science and Engineering Laboratories Center for Devices and Radiological Health

962 views • 63 slides

CSE182-L13

CSE182-L13. Mass Spectrometry Quantitation and other applications. What happens to the spectrum upon modification?. Consider the peptide MSTYER. Either S,T, or Y (one or more) can be phosphorylated

593 views • 49 slides

CSE182-L12

CSE182-L12. Mass Spectrometry Peptide identification. Mass-Charge ratio. The X-axis is not mass, but (M+Z)/Z Z=1 implies that peak is at M+1 Z=2 implies that peak is at (M+2)/2 M=1000, Z=2, peak position is at 501 Quiz: Suppose you see a peak at 501. Is the mass 500, or is it 1000?.

678 views • 43 slides

CSE182-L12

536 views • 40 slides

The role of genetics in the care of Hemophiliacs

516 views • 25 slides

Regulatory Pathway for Platform Technologies

Regulatory Pathway for Platform Technologies. Quynh Hoang Neurotherapeutic and Neurodiagnostic Devices Branch Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health. ASENT February 24, 2011. Disclaimer.

365 views • 23 slides

PE-Assembler: De novo assembler using short paired-end reads

PE-Assembler: De novo assembler using short paired-end reads. Pramila Nuwantha Ariyaratne. Outline. Method Read screening Seed building Contig extension Scaffolding Gap filling Result. Data-sets Used. Single end reads Paired end reads ReadLength ( from 25bp to 100bp)

342 views • 21 slides

ERIC Legal Developments in Employee Benefits

ERIC Legal Developments in Employee Benefits. March 21, 2018. This call is being recorded. To receive a copy of the call, please contact ERIC Member Services at memberservices@eric.org. Participation Procedure. Please place your line on mute

488 views • 20 slides

HLA antibodies in liver transplantation

HLA antibodies in liver transplantation. Hugo Kaneku, MD Post-Doctoral Research Fellow Department of Surgery Division of Liver and Pancreas Transplantation UCLA. Terasaki Festschrift January 24-26, 2014. HLA Abs in liver transplantation. 1. 12. Gordon RD, et al. Surgery 1986.

846 views • 20 slides

De-novo Assembly

De-novo Assembly. Day 4. The Challenge. Given many (millions or billions) of reads, produce a linear (or perhaps circular) genome Issues : Coverage Errors in reads Reads vary from very short (35bp) to quite long (800bp), and are double-stranded Non-uniqueness of solution

568 views • 19 slides

De Novo Sequencing v.s . Database Search

De Novo Sequencing v.s . Database Search. Bin Ma School of Computer Science University of Waterloo Ontario, Canada. protein DB. Two Computational Approaches. MS/MS Spectra. 1. 2. database search. de novo sequencing. peptides. peptides. Is This a True Peptide Identification?.

376 views • 17 slides

QUANTITATIVE ASPECTS OF DRUG ACTION

ilo s. By the end of this lecture you will be able to : . Recognize different dose response curves. Distinguish the therapeutic utility of each of these curves. Classify different types of antagonism. QUANTITATIVE ASPECTS OF DRUG ACTION. By Prof. Omnia Nayel

407 views • 17 slides

Gene identification by whole genome array CGH

Gene identification by whole genome array CGH. Richard Barber Richard.Barber@bwhct.nhs.uk 21st February Gene Discovery. Rearrangements. Large genomic rearrangements have been instrumental in identifying disease loci for many syndromes APC RB DMD UBE3A

304 views • 17 slides

P. Tang ( ??? ) ; RRC. Gan ( ??? ) Bioinformatics Center, Chang Gung University .

RNA Sequencing I: De novo RNAseq. P. Tang ( ??? ) ; RRC. Gan ( ??? ) Bioinformatics Center, Chang Gung University . Why Measure Gene Expression?. Unique set of genes are expressed at different growth conditions and at different stages. Experimental Workflow. cDNA/RNA fragment.

403 views • 16 slides

Sandra Ferns, on behalf of the LOTUS study group

De novo aneurysm formation and growth of untreated aneurysms 5-year MRA follow-up in a large cohort of patients with coiled aneurysms. Sandra Ferns, on behalf of the LOTUS study group. Depts of Neurosurgery and Radiology, AMC Amsterdam Depts of Neurology and Radiology, UMC Utrecht

307 views • 16 slides

Mx1Cre, (M, 2) Mx1Cre;p53loxp/ loxp , (MP, 2) Mx1Cre;LSLKrasG12D, (MK, 3)

RNA seq to understand mechanisms underlying transformation/self-renew of myeloid progenitor cells with KrasG12D activation and p53 deletion. Mx1Cre, (M, 2) Mx1Cre;p53loxp/ loxp , (MP, 2) Mx1Cre;LSLKrasG12D, (MK, 3) Mx1Cre;p53loxp/loxp;LSLKrasG12D, (MPK, 3 ). pIpC.

143 views • 5 slides

Detecting enriched regions (Chip- seq , RIP- seq ) Statistical evaluation of enriched regions

Bioinformatics Unit. OVERVIEW

194 views • 1 slides

Potentiated

Potentiated. Baseline. Depressed. Silent. A. DP N. LTP N. De novo LTD. De novo LTD. LTP N. LTP N. DP g. LTP g. *. B. *.

89 views • 1 slides